Cholesterol, statins and cancer

被引:92
作者
Brown, Andrew J. [1 ]
机构
[1] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2007年 / 34卷 / 03期
关键词
Akt; cholesterol; Hedgehog; Patched; statins; steroid hormones; sterol-regulatory element binding protein (SREBP); vitamin D; ELEMENT-BINDING PROTEIN; CELL-CYCLE PROGRESSION; PROSTATE-CANCER; LIPID-SYNTHESIS; RISK; MEMBRANE; ACTIVATION; PATHWAY; BIOSYNTHESIS; PREVENTION;
D O I
10.1111/j.1440-1681.2007.04565.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The link between cholesterol and cardiovascular disease is well-established. Emerging evidence is now forging a tantalizing link between cholesterol and cancer. 2. Results from a number of case-control studies have indicated that the commonly prescribed cholesterol-lowering drugs, the statins, may reduce the risk of certain cancers, although this area certainly remains controversial. 3. Herein, the recent literature examining statins and cancer is reviewed briefly and the relationship between a key cholesterol homeostatic pathway and signalling pathways that are involved in carcinogenesis is discussed. In particular, how the sterol-regulatory element binding protein, Akt and Hedgehog pathways may converge in cancer is reviewed.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 56 条
[1]   Patched1 functions as a gatekeeper by promoting cell cycle progression [J].
Adolphe, C ;
Hetherington, R ;
Ellis, T ;
Wainwright, B .
CANCER RESEARCH, 2006, 66 (04) :2081-2088
[2]   Statins and breast cancer: a smoking gun or guilt by association? [J].
Ahmed, Mohamed H. ;
Osman, Meissa M. ;
Alokail, Majed S. .
EXPERT OPINION ON DRUG SAFETY, 2006, 5 (05) :599-601
[3]   Perturbations of the AKT signaling pathway in human cancer [J].
Altomare, DA ;
Testa, JR .
ONCOGENE, 2005, 24 (50) :7455-7464
[4]   Repression of smoothened by patched-dependent (Pro-)Vitamin D3 secretion [J].
Bijlsma, Maarten F. ;
Spek, C. Arnold ;
Zivkovic, Danica ;
van de Water, Sandra ;
Rezaee, Farhad ;
Peppelenbosch, Maikel P. .
PLOS BIOLOGY, 2006, 4 (08) :1397-1410
[5]  
BISCHOFF F, 1963, PROG EXP TUMOR RES, V25, P412
[6]   Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer [J].
Bravi, F ;
Scotti, L ;
Bosetti, C ;
Talamini, R ;
Negri, E ;
Montella, M ;
Franceschi, S ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2006, 17 (06) :1014-1017
[7]   Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism [J].
Brown, AJ ;
Sun, LP ;
Feramisco, JD ;
Brown, MS ;
Goldstein, JL .
MOLECULAR CELL, 2002, 10 (02) :237-245
[8]   American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity [J].
Byers, T ;
Nestle, M ;
McTiernan, A ;
Doyle, C ;
Currie-Williams, A ;
Gansler, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (02) :92-119
[9]   Atorvastatin has cardiac safety at intensive cholesterol-reducing protocols for long term, yet its cancer-treatment doses with chemotherapy may cause cardiomyopathy even under Coenzyme-Q10 protection [J].
Caner, Metin ;
Sonmez, Bingur ;
Kurnaz, Ozlem ;
Aldemir, Caner ;
Salar, Seda ;
Altug, Tuncay ;
Bilir, Ayhan ;
Altinoz, Meric A. .
CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (04) :463-472
[10]  
Chen H W, 1978, Prog Exp Tumor Res, V22, P275